Disclaimer: This is an AI-generated article based off the transcript of my Youtube video on Sunlife versus Manulife.
Two of the most widely owned Canadian dividend stocks just hit fresh all-time highs in May 2026. Both pay safe, growing dividends. Both have multi-decade track records. And both have transformed into something much bigger than the life insurance companies most Canadians still think they are.
But if I had to put fresh money to work in only one of them today, I know exactly which one I’d pick — and the answer might surprise you given which one has actually been the better-performing stock over the last five years.
This is Manulife Financial (TSE:MFC) vs Sun Life Financial (TSE:SLF) — head-to-head, no fluff, with my verdict at the bottom.
Quick snapshot
| Metric | Manulife (MFC) | Sun Life (SLF) |
|---|---|---|
| Recent stock price | ~$53 | ~$100 |
| Market cap | ~$88B | ~$56B |
| Total AUM | ~$1.7 trillion | ~$1.6 trillion |
| 10-year price return | ~300% (~14.6% annualized) | ~119% (~8.19% annualized) |
| 5-year price return | ~167% | ~55% |
| Forward yield | ~3.7% | ~3.8% |
| Latest dividend hike | +10.2% (Feb 2026) | +4-5% (May 2026, to $0.96/q) |
| Trailing P/E | ~14.7x | ~18.3x |
| Adjusted ROE | ~16.5% | ~18.6% |
Both stocks have been incredible performers. Manulife has actually kept pace with the S&P 500 over the past decade — that is not what most Canadian investors expect from a life insurance company.
These aren’t really just life insurance companies anymore
This is the first thing most investors get wrong. If you still think of Manulife and Sun Life as just companies that sell life insurance policies, your mental model is outdated by a decade.
Manulife has roughly $1.7 trillion in assets under management. Sun Life has about $1.6 trillion. For reference, TD Bank — Canada’s largest bank by assets — sits around $2.1 trillion. These insurance companies are nearly the size of a Big 5 Canadian bank.
How they make money splits across two engines:
The underwriting engine. They collect more in premiums than they pay out in claims. This is the boring, predictable part of the business. Every insurance company — Intact, Manulife, Sun Life, iA Financial — lives or dies by underwriting.
The float. This is where it gets interesting. They collect your premiums today but don’t pay claims for decades. In between, they invest all that cash. It’s the exact model Warren Buffett used to build Berkshire Hathaway. Think of it like a casino in reverse — they take your bet, then make money off your money before they ever pay out.
On top of these two engines, both companies own enormous asset management arms:
- Manulife owns John Hancock Investment Management, Manulife Investment Management, and recently acquired Comvest Credit Partners — well over $1 trillion in combined AUM.
- Sun Life owns MFS Investment Management (the Boston-based mutual fund giant) and SLC Management — around $850 billion combined.
When you buy either of these stocks, you’re getting an insurance company, an investment portfolio, and a fund manager — all in one ticker.
Where the two companies actually differ
Manulife: the Asia growth bet
Manulife had a long-term care insurance problem from the 1990s and early 2000s. They sold policies assuming people would die in their mid-to-late 70s. Then medicine improved and people started living into their 90s. It was a slow-motion disaster on the balance sheet.
The fix has been a series of massive reinsurance deals:
- 2022 — Venerable variable annuity deal: $22 billion reinsured, $2.4 billion of capital released
- 2024 — Global Atlantic LTC deal: $13 billion total ($6 billion LTC), $1.2 billion released
- 2025 — RGA deal: $5.4 billion total ($2.4 billion LTC), $800 million released
Combined, they’ve cut their long-term care risk by 18% and freed up around $4.4 billion of capital. That capital has come back to shareholders through buybacks.
But the bigger story isn’t the cleanup — it’s where the growth is now coming from. Manulife’s Asia segment now makes up roughly 42% of segment operations. Asia delivered 11% APE sales growth and 22% core earnings growth in the most recent quarter, with Hong Kong new business value up 31%.
The Hong Kong angle is unique. Mainland Chinese tourists travel to Hong Kong specifically to buy life insurance because of favourable tax treatment. Industry-wide Hong Kong life insurance sales jumped 43% in the most recent quarter. Manulife is positioned in the right banks, the right airports, and the right distribution channels to capture all of it.
Add to that exposure to Japan, Indonesia, Singapore, Vietnam, and parts of mainland China, and you have one of the biggest pure plays on rising Asian middle-class wealth available on the TSX.
Sun Life: the diversified compounder
Sun Life never had Manulife’s legacy LTC problem. They’ve always been more diversified by nature — Canada, the US, Asia, and a massive asset management arm.
Where Sun Life has spent its capital over the last few years is on acquisitions to build out SLC Management — their alternatives platform. The list is long:
- Crescent Capital Group — private credit
- BentallGreenOak (BGO) — global real estate
- InfraRed Capital Partners — infrastructure
- DentaQuest (acquired 2022 for ~$2.5 billion USD) — US dental, ~36 million members
- Bell Partners — US multifamily real estate (announced 2026)
In Q1 2026, Sun Life also bought out the remaining stakes it didn’t already own in BGO and Crescent — paying about $1.77 billion combined. That was a real statement of intent.
If you’ve been wondering why Sun Life looks more complex than it used to, that’s why. They’re trying to become a mini-Brookfield by stacking up alternative asset managers on top of the insurance business.
Sun Life’s net income mix today is roughly 33% Canada, 28% Asset Management, 18% Asia, and 12% US. Much more balanced than Manulife. Less concentration risk. But also less torque if Asia keeps ripping.
The simplest way to describe the contrast: Manulife is getting simpler. Sun Life is getting more complex. Two completely different bets.
The 2008 dividend cut that still matters
You can’t talk about these two stocks without addressing the elephant in the room.
In August 2009, Manulife cut its quarterly dividend in half — from $0.26 to $0.13 per share. It saved them about $800 million a year and was framed as building “fortress capital” levels. Sun Life never made the same call. They held their dividend through the worst of the financial crisis.
A dividend cut from a blue chip Canadian insurance company that thousands of Canadian retirees relied on for income leaves a mark. Eighteen years later, it’s still the #1 reason a lot of older Canadian dividend investors prefer Sun Life over Manulife — and arguably the #1 reason Sun Life trades at a premium multiple to this day.
For what it’s worth, Manulife is a very different company now. Different management, different balance sheet, different segment mix. They’ve also raised the dividend every year since 2014 — twelve consecutive years — and the latest hike was +10.2% in February 2026. Sun Life just bumped its own dividend in May 2026 to $0.96 per share quarterly, roughly a 4-5% raise.
Both companies should grow their dividends steadily from here. Sun Life’s pace will probably stay in the mid-single digits. Manulife’s faster recent hikes are sustainable as long as the Asia growth engine keeps producing the kind of core earnings growth we’ve seen lately.
Growth catalysts for both
Asia is the obvious one for both companies. Rising middle class, aging populations, and very low insurance penetration in places like Indonesia, Vietnam, and the Philippines give both companies a long runway. Manulife benefits more because Asia is a larger share of its earnings.
India is the under-the-radar growth angle. Less than 1 in 20 Indians has life insurance today. India just became the most populous country on earth. Both Manulife and Sun Life have local joint ventures. Even capturing a tiny fraction of this market would meaningfully move the needle for either company.
Asset management gives Sun Life an edge. Private credit, real estate, infrastructure — these alternative asset classes are pulling in serious institutional money. Sun Life is further ahead in this race than Manulife, and now wholly owns BGO and Crescent.
Reinsurance optionality belongs to Manulife. They still have about 82% of their original LTC book on the balance sheet. Every future reinsurance deal will free up more capital that gets returned to shareholders. Sun Life doesn’t have this lever because they never had the legacy mess to clean up.
The risks on each
Manulife’s main risk is concentration. Over 40% of earnings from one geographic region is a lot. When Asia is hot — like it has been — the stock looks brilliant. If Asia slows down, the stock will sting. There’s also foreign exchange risk: a stronger Canadian dollar is a headwind for Manulife in a way it isn’t really for Sun Life. And the most recent quarter showed some large outflows from the Global Wealth & Asset Management segment. Management called it a one-off. If it isn’t, that becomes a problem.
Sun Life’s risk is execution. The US dental business has hit a rough patch — Medicaid redeterminations have forced Sun Life to walk back guidance on the DentaQuest segment. It will likely normalize over time, but it’s a short-term overhang. They’re also spending heavily on acquisitions — Bell Partners, the BGO and Crescent buyouts — and acquisitions don’t always work out. Capital being deployed on M&A is capital not being returned directly to shareholders.
Valuation today
This is where things get really interesting.
Running both companies through a discounted cash flow analysis at Stocktrades Premium, both are still showing decent upside to fair value. Manulife shows a target around $56.70, with Sun Life closer to $112.84 — both roughly low double-digit upside from current levels with reasonable assumptions and a 15% margin of safety baked in.
On earnings multiples — and you want to be using core earnings here, because reported free cash flow gets messy with insurance companies:
- Manulife trades at about 14.7x trailing earnings — roughly a 50% discount to its 10-year average. Forward P/E sits around 11.7x.
- Sun Life trades at about 18.3x trailing — actually trading above its historical average. Forward P/E around 12.7x.
So Manulife is the cheaper stock by a wide margin. Why?
Sun Life has been the more efficient business. Higher return on equity (around 18.6% on an adjusted basis versus 16.5% for Manulife), no legacy long-term care drag, and the diversification of having Canada, the US, Asia, and a giant asset manager all firing. The market is willing to pay up for that quality.
Manulife is the cheaper option, but it comes with concentrated Asia exposure. If that segment slows, the discount to Sun Life can stay or widen.
My pick: Sun Life
If I had to put fresh money to work in just one of these today, it’s Sun Life.
Here’s why:
- Higher return on equity. Sun Life is the more efficient operator.
- Cleaner capital position. No legacy LTC drag, more diversified earnings base.
- They never cut the dividend in 2008. That track record matters.
- The acquisition strategy is building real long-term optionality. Private credit, real estate, infrastructure — these are growth engines for the next decade.
- A lot of Manulife’s upside feels priced in. The stock has been on a tear and the market is pricing in continued Asia outperformance. If Asia stumbles, the multiple shrinks fast.
That said, I’m not saying Manulife is a bad investment. It absolutely isn’t. The Asia growth story is real, the dividend is growing faster, and the valuation is cheaper. You could very reasonably make the opposite call.
If you came to me and said “Dan, which one should I own?” — my answer would be Sun Life, but it’s a 60/40 lean, not a slam dunk.
Why owning both can make sense
These two companies are different enough that owning both isn’t crazy. You get more concentrated Asia exposure through Manulife, and you get more diversification through Sun Life — across geography (more US exposure), and across business model (more asset management).
A lot of investors get tripped up on owning two companies in the same sector. But Manulife and Sun Life have evolved into very different businesses, with different growth engines and different risk profiles. Owning both gives you a balanced bet on Canadian financial services without doubling up on the same thesis.
Bottom line
Both Manulife and Sun Life are top Canadian dividend stocks. Both have multi-decade track records, growing dividends, and trillion-dollar asset management arms most investors don’t even realize exist. Both are arguably stronger businesses today than they’ve been in 15 years.
If I’m picking one for fresh capital today, it’s Sun Life — higher ROE, cleaner balance sheet, longer dividend track record, and asset management optionality.
If you’re more comfortable taking concentrated risk for higher potential reward, Manulife is genuinely compelling — bigger Asia exposure, cheaper valuation, faster dividend growth, and a clean reinsurance playbook.
Either way, both should be on the shortlist of any Canadian dividend investor building a long-term portfolio.
